Condition
RAD51D Gene Mutation
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Completed1
Suspended1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06033092Phase 2Completed
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
NCT05420064Not ApplicableRecruiting
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
NCT02993068Not ApplicableSuspended
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
NCT04294927Not ApplicableRecruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Showing all 4 trials